IL25 and inflammatory bowel disease: The considerable decrease in IL-25 in both inflamed intestinal mucosa and serum in patients with dilated IBD and healthy controls, as well as non-inflamed tissues and serum in patients with quiescent UC and CD, is cause for concern.